Biotechnology

MarketResearch.com has announced the addition of the new report 'Insulin Delivery Systems Market Forecast to 2014' to their collection of Diabetes market reports. For more information, visit http://www.marketresearch.com/RNCOS-v3175/Insulin-...

Trovagene, Inc. , a developer of transrenal molecular diagnostics, today announced that Charlie Rodi, Ph.D. has been named Vice President and Chief Technology Officer. Dr. Rodi brings a wealth of management and scientific leadership to the position....

Yubico, the leading provider of simple, open online identity protection, today announced a successful implementation of YubiKey two-factor authentication with the free, open source password manager software Password Safe. The joint solution offers ...

MarketResearch.com has announced the addition of the new report 'Global Active Pharmaceutical Ingredient Market Trends, Competitive Landscape And Forecasts ,' to their collection of Pharmaceuticals market reports. For more information, visit http://...

Valkee and University of Oulu Publish the First Clinical Trial on Bright Light Therapy Channeled via ear Canals in Seasonal Depression

ResearchMoz: Oxygen Concentrator Market Shares, Strategies and Forecasts, Worldwide, 2012 to 2018

Biotech company Pharming Group NV announced today that it has entered into an agreement with Transmedic Pte Ltd. , a privately owned Singapore based specialty healthcare company, for the commercialization of RUCONEST for the treatment of acute ...

Aeolus Pharmaceuticals, Inc.

The American Diabetes Association is concerned that funding for core discretionary and mandatory health programs included in the President's Fiscal Year 2013 Budget falls far short of the investment needed to stop the diabetes epidemic.

Amgen will present at the Leerink Swann Global Healthcare Conference at 9:30 a.m. Eastern Standard Time on Thursday, Feb. 16, 2012, at the Waldorf Astoria Hotel in New York City. Jonathan M. Peacock, executive vice president and chief financial ...

as a sign that 'meaningful use' requirements for EMR systems are having an effect on this market.

The American Diabetes Association is concerned that funding for core discretionary and mandatory health programs included in the President's Fiscal Year 2013 Budget falls far short of the investment needed to stop the diabetes epidemic.

Medisafe 1 Technologies to Start the $1MM Stock Repurchase Program of 10MM Shares up to 10 Cents a Share

Regeneron Pharmaceuticals, Inc. will webcast its presentation at the Leerink Swann 2012 Global Healthcare Conference on Wednesday, February 15, 2012. The presentation is scheduled for 9:00 a.m. Eastern Time. The session may be accessed through the ...

Gen-Probe Incorporated today reported financial results for the fourth quarter of 2011. Total revenues in the quarter grew 16%, to a new record of $158.2 million, while non-GAAP earnings per share increased 18%, to a new high of $0.72.

Hospira, Inc. , the world's leading provider of injectable drugs and infusion technologies, today announced the hiring of several new leaders to strengthen the company's quality and compliance capabilities, including the appointment of Zena G. ...

Recombinant Data and EMC Greenplum Offer Complimentary Clinical Data Consults at HIMSS12

Ten years ago today, a task force comprised of Indianapolis business, academic and civic leaders came together to develop a strategy for Indiana's life sciences sector that would catapult the state's legacy of strong life sciences companies and ...

ChemoCentryx, Inc. announced today the completion of its initial public offering of 4,500,000 shares of common stock. In addition, the underwriters of its initial public offering exercised their over-allotment option in full and purchased an ...

The Society for Brain Mapping and Therapeutics announced today that the organization will hold its 9 Annual World Congress on Brain, Spinal Cord Mapping, and Image Guided Therapy from June 2-4, 2012 in Toronto, Canada. The world's top brain and ...